Curis Inc SEC filings CRIS
Curis Inc has 1,006 filings in SEC EDGAR's recent list, going back to Jun 3, 2005. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Aug 12, 2026 | — |
| DRS | Filing | Jul 17, 2026 | — |
| EFFECT | Filing | Mar 20, 2026 | — |
| CORRESP | Letter to the SEC | Mar 17, 2026 | — |
| UPLOAD | Letter from the SEC | Feb 19, 2026 | — |
| EFFECT | Filing | Aug 18, 2025 | — |
| CORRESP | Letter to the SEC | Aug 14, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 13, 2025 | — |
| EFFECT | Filing | May 19, 2025 | — |
| CORRESP | Letter to the SEC | May 15, 2025 | — |
| UPLOAD | Letter from the SEC | May 13, 2025 | — |
| EFFECT | Filing | Jan 7, 2025 | — |
| CORRESP | Letter to the SEC | Jan 3, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 31, 2024 | — |
| EFFECT | Filing | Apr 12, 2024 | — |
| CORRESP | Letter to the SEC | Apr 10, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 13, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 3, 2024 | — |
| CORRESP | Letter to the SEC | Dec 21, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 12, 2023 | — |
| EFFECT | Filing | Apr 14, 2022 | — |
| POSASR | Filing | Feb 24, 2022 | — |
| CT ORDER | Filing | Jun 16, 2021 | — |
| CT ORDER | Filing | Apr 17, 2019 | — |
| CT ORDER | Filing | Jul 10, 2018 | — |
| EFFECT | Filing | May 17, 2018 | — |
| CORRESP | Letter to the SEC | May 15, 2018 | — |
| UPLOAD | Letter from the SEC | May 14, 2018 | — |
| CT ORDER | Filing | Mar 12, 2018 | — |
| CT ORDER | Filing | Mar 12, 2018 | — |
| CT ORDER | Filing | Apr 14, 2017 | — |
| EFFECT | Filing | Dec 16, 2016 | — |
| CORRESP | Letter to the SEC | Dec 15, 2016 | — |
| UPLOAD | Letter from the SEC | Dec 14, 2016 | — |
| CT ORDER | Filing | Dec 1, 2016 | — |
| EFFECT | Filing | Sep 2, 2015 | — |
| CORRESP | Letter to the SEC | Aug 31, 2015 | — |
| CORRESP | Letter to the SEC | Aug 12, 2015 | — |
| CT ORDER | Filing | Aug 7, 2015 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2015 | — |
| EFFECT | Filing | May 1, 2015 | — |
| CORRESP | Letter to the SEC | Apr 29, 2015 | — |
| UPLOAD | Letter from the SEC | Apr 23, 2015 | — |
| CT ORDER | Filing | Apr 23, 2015 | — |
| EFFECT | Filing | Jul 22, 2013 | — |
| CT ORDER | Filing | Apr 10, 2013 | — |
| CT ORDER | Filing | Dec 4, 2012 | — |
| CT ORDER | Filing | Dec 4, 2012 | — |
| CT ORDER | Filing | Aug 17, 2012 | — |
| D | Filing | May 4, 2012 | — |
| CT ORDER | Filing | Apr 29, 2011 | — |
| EFFECT | Filing | Jan 11, 2011 | — |
| CT ORDER | Filing | Nov 18, 2009 | — |
| UPLOAD | Letter from the SEC | Nov 13, 2009 | — |
| CORRESP | Letter to the SEC | Oct 16, 2009 | — |
| UPLOAD | Letter from the SEC | Oct 13, 2009 | — |
| CORRESP | Letter to the SEC | Oct 2, 2009 | — |
| CORRESP | Letter to the SEC | Oct 2, 2009 | — |
| CORRESP | Letter to the SEC | Sep 18, 2009 | — |
| UPLOAD | Letter from the SEC | Sep 14, 2009 | — |
| CT ORDER | Filing | Jun 30, 2009 | — |
| EFFECT | Filing | Aug 18, 2008 | — |
| CT ORDER | Filing | May 9, 2008 | — |
| CT ORDER | Filing | May 9, 2008 | — |
| EFFECT | Filing | Sep 10, 2007 | — |
| REGDEX | Auto-generated paper document | Aug 13, 2007 | — |
| UPLOAD | Letter from the SEC | Apr 19, 2006 | — |
| CORRESP | Letter to the SEC | Mar 21, 2006 | — |
| CORRESP | Letter to the SEC | Mar 21, 2006 | — |
| NT 10-K | Form 12b-25 | Mar 17, 2006 | Dec 31, 2005 |
| UPLOAD | Letter from the SEC | Dec 7, 2005 | — |
| CORRESP | Letter to the SEC | Nov 28, 2005 | — |
| UPLOAD | Letter from the SEC | Nov 18, 2005 | — |
| NT 10-Q | Form 12b-25 | Nov 10, 2005 | Sep 30, 2005 |
| CORRESP | Letter to the SEC | Nov 9, 2005 | — |
| UPLOAD | Letter from the SEC | Nov 1, 2005 | — |
| CORRESP | Letter to the SEC | Sep 28, 2005 | — |
| UPLOAD | Letter from the SEC | Aug 22, 2005 | — |
| CORRESP | Letter to the SEC | Jun 20, 2005 | — |
| UPLOAD | Letter from the SEC | Jun 7, 2005 | — |
Showing 80 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CRIS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Lexington, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1108205
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.